摘要
目的分析对功能性消化不良患者使用莫沙必利联合舒肝解郁胶囊的治疗效果。方法对我院200例功能性消化不良患者进行随机分组,对对照组和观察组分别实施单一莫沙必利以及莫沙必利联合舒肝解郁胶囊治疗。结果两组均取得一定效果,但相比对照组,观察组患者的治疗效果更好,差异有统计学意义(P<0.05)。而两组患者的治疗安全性差异无统计学意义(P>0.05)。结论使用莫沙必利联合舒肝解郁胶囊的方法对功能性消化不良患者可起到更好的治疗效果。
Objective To analyze the functional dyspepsia patients using mosapride combined with Shuganjieyu capsule treatment. Methods 200 cases of patients with functional dyspepsia were randomly divided into two groups in our hospital, were implemented on a single drug control group and the observation group of mosapride and mosapride combined with Shuganjieyu capsule treatment. Results The two groups had a certain effect, but compared with the control group, the treatment effect of the observation group was better, the difference was statistically significant（P〈0.05）. And there was no significant difference between the two groups in the treatment safety（P〉0.05）. Conclusion The use of mosapride method combined with Shuganjieyu capsule on patients with functional dyspepsia can play a better therapeutic effect.
出处
《中国继续医学教育》
2016年第30期157-158,共2页
China Continuing Medical Education
